Sadegh Feizollahzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sadegh Feizollahzadeh has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Amin Sedokani
Student research committee, Urmia University of Medical Sciences, Urmia, Iran
1 shared publication Babak Farokhi
Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran
1 shared publication- Davar Amani
Department of Immunology, Medicine Faculty, Shahid Beheshti University of Medical Science, Tehran, Iran.
1 shared publication - Hasan Yusefzadeh
Department of Health Economics and Management, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran
1 shared publication Hiva Mohammad Amini
Medical Student, Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran
1 shared publicationJavad Rasuli
Department of Public Health, Urmia University of Medical Sciences, Urmia, Iran
1 shared publication
Latest Publications
- Open Access
- 1 February 2025
- Published by Apex Publishing in Health Science Monitor
- Vol. 4 (1) , 7-14
Evaluation of COVID-19 vaccination status and immune response among staff at Shahid Motahari Hospital, Urmia, 2021
Background & Aims: The Ministry of Health and Treatment implemented vaccination as one of the primary strategies to control the coronavirus disease 2019 (COVID-19) pandemic. Given their critical role in treatment and disease control, healthcare workers were prioritized for vaccination. This study aims to assess the vaccination status and level ...
- 1 February 2025
- Published by Apex Publishing in Health Science Monitor
- Vol. 4 (1) , 7-14
Open AccessEvaluation of COVID-19 vaccination status and immune response among staff at Shahid Motahari Hospital, Urmia, 2021
Background & Aims: The Ministry of Health and Treatment implemented vaccination as one of the primary strategies to control the coronavirus disease 2019 (COVID-19) pandemic. Given their critical role in treatment and disease control, healthcare workers were prioritized for vaccination. This study aims to assess the vaccination status and level ...
- Open Access
- 1 September 2023
- Published by Apex Publishing in Studies in Medical Sciences
- Vol. 34 (6) , 330-337
INVESTIGATING THE PREVALENCE OF AUTOIMMUNE THYROID DISEASES IN CHILDREN WITH CELIAC DISEASE IN URMIA CITY, IRAN
Background & Aim: Celiac disease is an autoimmune disorder involving the small intestine caused by gluten consumption. In addition to the complications caused by the involvement of the digestive system, many autoimmune complications, especially autoimmune thyroid diseases, are also common in these patients. The aim of this study was to ...
- 1 September 2023
- Published by Apex Publishing in Studies in Medical Sciences
- Vol. 34 (6) , 330-337
Open AccessINVESTIGATING THE PREVALENCE OF AUTOIMMUNE THYROID DISEASES IN CHILDREN WITH CELIAC DISEASE IN URMIA CITY, IRAN
Background & Aim: Celiac disease is an autoimmune disorder involving the small intestine caused by gluten consumption. In addition to the complications caused by the involvement of the digestive system, many autoimmune complications, especially autoimmune thyroid diseases, are also common in these patients. The aim of this study was to ...
- Open Access
- 1 July 2020
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 14, 2607-2611
Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19
In March 2020, the WHO declared the COVID-19 disease as a pandemic disease. There have been studies on the COVID-19 to find a certain treatment, but yet, there is no certain cure. In this article, we present a possible way to treat severe cases of COVID-19. Based on the previous studies, there are similarities between the spike antigens of SARS-CoV and SARS-CoV-2 viruses. It is expected that these similarities (structural and affinity to the receptor of ACE2) can lead to the same pathophysiological activity of the virus by the use of ACE2 and FcγRII (the antibody-dependent enhancement mechanism). Therefore, we propose a way of washing out (by plasmapheresis) the possible antibodies against the spike protein of the virus out of patients’ plasma to stop the antibody-dependent enhancement (ADE)-mediated infection of the immune system cells at the first phase of the treatment and simultaneous use of the anti-ACE2 with anti-FcγRII monoclonal antibodies at the second phase. We propose these procedures for the patients that have no significant response for typical anti-viral, ARDS and conservative therapies, and the disease persists or progresses despite sufficient therapies.
- 1 July 2020
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 14, 2607-2611
Open AccessPlasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19
In March 2020, the WHO declared the COVID-19 disease as a pandemic disease. There have been studies on the COVID-19 to find a certain treatment, but yet, there is no certain cure. In this article, we present a possible way to treat severe cases of COVID-19. Based on the previous studies, there are similarities between the spike antigens of SARS-CoV and SARS-CoV-2 viruses. It is expected that these similarities (structural and affinity to the receptor of ACE2) can lead to the same pathophysiological activity of the virus by the use of ACE2 and FcγRII (the antibody-dependent enhancement mechanism). Therefore, we propose a way of washing out (by plasmapheresis) the possible antibodies against the spike protein of the virus out of patients’ plasma to stop the antibody-dependent enhancement (ADE)-mediated infection of the immune system cells at the first phase of the treatment and simultaneous use of the anti-ACE2 with anti-FcγRII monoclonal antibodies at the second phase. We propose these procedures for the patients that have no significant response for typical anti-viral, ARDS and conservative therapies, and the disease persists or progresses despite sufficient therapies.
- Open Access
- 8 October 2019
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (2) , e23067
The economic efficiency of clinical laboratories in public hospitals: A case study in Iran
Introduction: Clinical laboratories are identified as one of the most important and expensive units of the health system. Therefore, it is essential to pay attention to these units' cost efficiency. This study purpose was to evaluate the economic efficiency of hospitals' laboratory units affiliated to Urmia University of Medical Sciences (UMSU), in order to assess their performance. Methods: This research was a descriptive‐analytic study that was accomplished in 2017. The statistical population of the study included all of the hospitals' clinical laboratories affiliated to UMSU. Moreover, DEA method and Deap 2.1 software were used to analyze data. In this study, technical and allocative efficiencies of the studied laboratory units were also calculated in addition to the determination of the economic efficiency of the laboratories. Results: The average economic efficiency of clinical laboratories calculated by DEA in 2017 was 0.676. This value was lower than the allocative and technical efficiency scores, which indicates that these units could attain full efficiency by reducing their costs without having any effect on output values. Moreover, about 14 percent of the clinical laboratory units were economically efficient. In addition, it is noteworthy to state that, from total of university hospital laboratories, only three hospitals had no economic excess or deficiency values of inputs. Conclusion: Considering that 76% of laboratory units have not been economically efficient, it is necessary for the laboratory managers to consider optimum allocating of resources, with respect to the cost of laboratory equipment and inputs in order to increase their units' economic efficiency.
- 8 October 2019
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (2) , e23067
Open AccessThe economic efficiency of clinical laboratories in public hospitals: A case study in Iran
Introduction: Clinical laboratories are identified as one of the most important and expensive units of the health system. Therefore, it is essential to pay attention to these units' cost efficiency. This study purpose was to evaluate the economic efficiency of hospitals' laboratory units affiliated to Urmia University of Medical Sciences (UMSU), in order to assess their performance. Methods: This research was a descriptive‐analytic study that was accomplished in 2017. The statistical population of the study included all of the hospitals' clinical laboratories affiliated to UMSU. Moreover, DEA method and Deap 2.1 software were used to analyze data. In this study, technical and allocative efficiencies of the studied laboratory units were also calculated in addition to the determination of the economic efficiency of the laboratories. Results: The average economic efficiency of clinical laboratories calculated by DEA in 2017 was 0.676. This value was lower than the allocative and technical efficiency scores, which indicates that these units could attain full efficiency by reducing their costs without having any effect on output values. Moreover, about 14 percent of the clinical laboratory units were economically efficient. In addition, it is noteworthy to state that, from total of university hospital laboratories, only three hospitals had no economic excess or deficiency values of inputs. Conclusion: Considering that 76% of laboratory units have not been economically efficient, it is necessary for the laboratory managers to consider optimum allocating of resources, with respect to the cost of laboratory equipment and inputs in order to increase their units' economic efficiency.
- Open Access
- 12 July 2014
- Vol. 4 (1) , 77-81
Augmented Plasma Adiponectin after Prolonged Fasting During Ramadan in Men
Background: Intermittent fasting during Ramadan entails major changes in metabolism and energy expenditure. This study sought to determine effect of the Ramadan fasting on serum levels of adiponectin and tumor necrosis factor-α (TNF-α) as two inter-related peptides involved in cells sensitivity to insulin and glucose metabolism.
- 12 July 2014
- Vol. 4 (1) , 77-81
Open AccessAugmented Plasma Adiponectin after Prolonged Fasting During Ramadan in Men
Background: Intermittent fasting during Ramadan entails major changes in metabolism and energy expenditure. This study sought to determine effect of the Ramadan fasting on serum levels of adiponectin and tumor necrosis factor-α (TNF-α) as two inter-related peptides involved in cells sensitivity to insulin and glucose metabolism.
- 1 June 2012
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 94 (2) , 216-221
Promoter region polymorphisms in the transforming growth factor beta-1 (TGFβ1) gene and serum TGFβ1 concentration in preeclamptic and control Iranian women
- 1 June 2012
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 94 (2) , 216-221
Promoter region polymorphisms in the transforming growth factor beta-1 (TGFβ1) gene and serum TGFβ1 concentration in preeclamptic and control Iranian women